Cargando...

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial

BACKGROUND: Smoking cessation is a key component of secondary cardiovascular disease prevention. Varenicline, a partial α4β2 nicotinic acetylcholine receptor agonist, is effective for smoking cessation in healthy smokers, but its efficacy and safety in smokers with cardiovascular disease are unknown...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rigotti, Nancy A., Pipe, Andrew L., Benowitz, Neal L., Arteaga, Carmen, Garza, Dahlia, Tonstad, Serena
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4096941/
https://ncbi.nlm.nih.gov/pubmed/20048210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.109.869008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!